Original Research ARTICLE
Neutrophil Extracellular Traps Enhance Early Inflammatory Response in Sendai Virus-Induced Asthma Phenotype
- Department of Medicine, Division of Rheumatology, Washington University School of Medicine, Saint Louis, MO, USA
Paramyxoviral infection in childhood has been linked to a significant increased rate of asthma development. In mice, paramyxoviral infection with the mouse parainfluenza virus type I, Sendai virus (Sev), causes a limited bronchiolitis followed by persistent asthma traits. We have previously shown that the absence of cysteine protease dipeptidyl peptidase I (DPPI) dampened the acute lung inflammatory response and the subsequent asthma phenotype induced by Sev. Adoptive transfer of wild-type neutrophils into DPPI-deficient mice restored leukocyte influx, the acute cytokine response, and the subsequent mucous cell metaplasia that accompanied Sev-induced asthma phenotype. However, the exact mechanism by which DPPI-sufficient neutrophils promote asthma development following Sev infection is still unknown. We hypothesize that neutrophils recruited to the alveolar space following Sev infection elaborate neutrophil extracellular traps (NETs) that propagate the inflammatory cascade, culminating in the eventual asthma phenotype. Indeed, we found that Sev infection was associated with NET formation in the lung and release of cell-free DNA complexed to myeloperoxidase in the alveolar space and plasma that peaked on day 2 post infection. Absence of DPPI significantly attenuated Sev-induced NET formation in vivo and in vitro. Furthermore, concomitant administration of DNase 1, which dismantled NETs, or inhibition of peptidylarginine deiminase 4 (PAD4), an essential mediator of NET formation, suppressed the early inflammatory responses to Sev infection. Lastly, NETs primed bone marrow-derived cells to release cytokines that can amplify the inflammatory cascade.
Respiratory viral illnesses are common in early life. A majority of children with an initial episode of viral-induced bronchiolitis will have recurrent wheezing, prompting the association between viral infection, and subsequent development of asthma (1–3). In the mouse, infection with the paramyxovirus Sendai virus (Sev) causes a limited bronchiolitis followed by chronic persistent asthma traits characterized by mucous cell metaplasia and airway hyperreactivity (AHR) (4). We have previously shown that the asthma phenotype was attenuated in the absence of dipeptidyl peptidase I (DPPI), a cysteine protease with many immunomodulatory activities (5). This attenuation was accompanied by significant reduction in the number of alveolar neutrophils and local production of inflammatory cytokines in the acute phase of infection. Adoptive transfer of WT neutrophils into DPPI-deficient mice led to enhanced accumulation of DPPI-deficient neutrophils and inflammatory cytokine production in the alveolar space on day 4 post-infection (PI) and subsequent asthma phenotype development. The fact that DPPI-deficient neutrophils exhibited normal chemotaxis in response to various stimuli (5) but failed to accumulate at the site of inflammation (alveolar space) suggests a yet-to-be defined mechanism by which DPPI and DPPI-sufficient neutrophils modulate the early inflammatory responses to Sev.
Neutrophil extracellular traps (NETs) were initially described as a neutrophil defense mechanism to trap and kill bacteria (6). NETs have since been implicated in the pathogenesis of several inflammatory diseases, including bronchial asthma (7). Herein, we showed that Sev infection led to NET formation in the lung of WT mice. We also established that DPPI-deficient neutrophils exhibited a defect in NET formation in vitro in response to multiple stimuli. We hypothesized that the absence of DPPI attenuated NET formation in response to Sev infection, thus interrupting the inflammatory cascade and suppressing the ongoing leukocyte influx. Indeed, administration of DNase 1, which dismantled NETs, reduced free DNA–myeloperoxidase (MPO) complexes in the alveolar space and plasma, as well as attenuating the early inflammatory responses to Sev infection. Inhibition of peptidylarginine deiminase 4 (PAD4), an essential mediator of NET formation also suppressed alveolar leukocyte accumulation and cytokine production in the acute phase of infection, confirming the contribution of NETs to Sev-induced phenotype. Moreover, NETs from Sev-infected bronchoalveolar lavage fluid (BALF) stimulated bone marrow-derived cells (BMDCs) [dendritic cells (DCs) and macrophages] to release inflammatory cytokines.
Materials and Methods
Dipeptidyl peptidase I−/− mice were generated in 129/SvJ as previously described (8) and backcrossed to C57BL/6J for >10 generations. Microsatellite genotyping showed that DPPI−/− mice were 99.2% congenic with C57BL/6J mice (The Jackson Laboratory). WT C57BL/6J mice were obtained from The Jackson Laboratory. WT and DPPI−/− mice were kept in pathogen-free environment until the time of Sev infection. All animal experiments were performed in compliance with federal laws and in strict accordance with the guidelines established by the Division of Comparative Medicine at Washington University in St. Louis.
Mice of 6–8 weeks of age were anesthetized with isoflurane and inoculated intranasally (i.n.) with 2,500 50% egg infectious dose of Sev (Fushimi strain) as previously described (5). Experimental infection with Sev was performed in biohazard containment facility. Some animals received DNase 1 (0.5 mg i.n./mouse) on days 0–2. Cl-amidine, a pan-PAD inhibitor (cat#506282, Calbiochem) was dissolved in DMSO/PBS (5% v/v) and administered i.p. at 10 mg/kg daily on days −2 and −1 prior to infection then twice a day on days 0–2 PI. Controls received the same volume of DMSO/PBS (5% v/v). At different time points, mice were sacrificed and their blood, BALF, and lung harvested for cell count, cytokine, MPO–DNA, and histologic analysis.
Lung and BALF Analysis
After sacrifice, BALF was obtained as previously described (5). The cells were pelleted and analyzed by flow cytometry using: FITC anti-CD69 (cat# 561929; BD Pharmingen), PerCP anti-CD8a (cat# 45-0081-82; eBioscience), APC anti-CD4 (cat# 100516; BioLegend), PE anti-CD11c (cat#553802, BD Pharmingen), anti-Siglec-H (cat# MCA4647GA, AbD Serotec, Raleigh, NC, USA), APC anti-CD317 (cat# 127015, BioLegend), PerCP anti-CD11b (cat# 101229, BioLegend), FITC anti-rat IgG (cat# 712-095-150, Jackson ImmunoResearch Laboratories). In general, 106 cells were blocked with the anti-FcR mAb 2.4G2, stained with the indicated antibodies for 20 min at 4°C and then washed and resuspended in FACS buffer for analysis. Flow cytometry was performed on a BD FACSCalibur™. Data analysis was performed using BD CellQuest™ Pro software. Cell-free BALF was subjected to cytokine analysis by cytometric bead arrays (CBA) or MPO–DNA complex analysis. The lung was snap frozen in OCT compound and examined for in vivo NET formation.
In Vivo NET Detection
Cross sections (9 μm) of OCT-embedded frozen lung tissues were fixed in 4% paraformaldehyde, blocked in 8% BSA in PBS and incubated with the primary antibodies: anti-Histone H2B (1:100 dilution; Cat # SC-8651; Santa Cruz Biotechnology), anti-mouse MPO (1:100 dilution; Cat # HM1051BT; Hycult Biotech) followed by the appropriate rhodamine red- or FITC-conjugated secondary antibody (1:100–1:200; Jackson ImmunoResearch Laboratories). DNA was stained with DAPI. All images were acquired with QCapture software on a Nikon Eclipse microscope.
In Vitro NET Induction
Neutrophils were isolated from bone marrow as previously described (9). Isolated neutrophils were seeded on Thermanox plastic coverslips (Cat # 174950, Thermo Fisher Scientific Inc.) or 5-mm round glass coverslips (Cat # 101413-528, VWR), placed in 24-well plates (75,000 cells/well) and incubated for 1 h at 37°C to allow adherence to coverslips. The following activating agents were used: LPS (10 μg/ml, Cat # L2762, Sigma-Aldrich), PMA (10 nM, cat# P8137, Sigma-Aldrich) or Sev (5,000), and rmTNF-α (10 μg/ml, cat# 410-MT, R&D Systems). After 30 min of stimulation, cells were fixed with 4% paraformaldehyde in PBS overnight and the DNA was stained with Sytox green (Cat # S7020, Invitrogen). NETs were visualized on a Nikon Eclipse fluorescence microscope and low magnification images (40×) were acquired with QCapture software on non-overlapping random images (7–11 separate fields/coverslips, derived from 3 wells/condition or genotype). NETs were manually identified on acquired images as Sytox-positive structures emanating from neutrophils with an overall length at least twice as long as the cell diameter (10) and expressed as percentage of neutrophils with released DNA. Each experiment was repeated at least three times.
Anti-MPO antibody (5 μg/ml, cat# HM 1051BT, Hycult Biotech Inc) was used to coat 96-well plate overnight at 4°C. After three washes with washing buffer (PBS with 0.05% Tween 20), 20 μl of BALF or plasma samples were added to the wells with 80-μl incubation buffer containing a peroxidase-labeled anti-DNA monoclonal antibody (dilution 1:25, cat# 11544675001, Cell Death Detection ELISA, Roche). The plate was incubated for 2 h at room temperature. After three washes, 100 μl of peroxidase substrate (cat# DY999, R&D Systems) was added. The reaction was stopped with 1M H2SO4 and OD of samples measured at 450 nm (Molecular Devices SpectraMax Plus 384). Specific OD was obtained by subtracting total OD from background OD generated without the addition of peroxidase-labeled anti-DNA antibody (less than 10%).
Cytokine concentrations in BALF samples and co-cultures were measured using the CBA for Mouse Inflammation Kit (cat# 552364, BD Biosciences), according to the manufacturer’s protocols.
In Vitro Co-cultures
Murine bone marrow cells were cultured in vitro with GM-CSF (10 μg/ml, cat# PMC2015, Thermo Fisher Scientific) and Il-4 (5 μg/ml, cat# 404-ML/CF, R&D Systems) for 7 days. Cultured cells were plated in 24-well plates at 0.5 × 106 cells/well. BALF collected on day 3 from Sev-infected mice were added at a final dilution of 44%. Supernatants were collected 2 days later and cytokine concentrations were analyzed by CBA. Baseline cytokine levels from BMDCs alone are subtracted from co-culture cytokine levels and values are presented as% of mean WT level, which is set at 100%.
Comparisons between two groups were performed by student’s t-test and comparisons between multiple groups (≥3) were performed by one-way ANOVA and Bonferroni’s correction for multiple comparisons was performed. Numerical data were expressed as mean ± SEM. P values <0.05 were considered significant.
Sev Infection Induces NET Formation In Vivo and In Vitro
WT C57BL/6J and DPPI-deficient (DPPI−/−) mice were infected i.n. with 2,500 50% egg infectious dose of Sev as previously described (5). On day 3 PI, mice were sacrificed and their lung examined for NET formation by immunostaining with anti-histone and anti-MPO antibodies; DAPI stained DNA. NETs were easily detected in WT lung but greatly decreased in DPPI−/− mice (Figure 1A). Concomitant administration of DNase 1, which dismantled NETs (11, 12), also suppressed Sev-induced NET formation in Sev-infected WT mice (Figure 1A).
Figure 1. Sev infection induces pulmonary NETs. WT and DPPI−/− mice were infected with Sev and their blood, lung, and BALF harvested on the indicated day PI. (A) Frozen lung sections from day 3 PI were stained for histone (green) and MPO (red). DAPI stained nuclei blue. The absence of DPPI and DNase 1 treatment suppressed NET formation. (B–D) BALF fluid and plasma from Sev-infected animals were collected on the indicated days and assayed for levels of MPO–DNA complexes. Values represent increase over baseline (obtained from uninfected mice) and expressed as mean ± SEM, n = at least five mice per genotype/treatment group. Scale bars = 100 μm. *P < 0.05, ***P < 0.001.
To further quantify the NET content in Sev-infected mice we measured concentration of MPO–DNA complexes in the BALF and in plasma. The concentration of MPO–DNA complexes in BALF and plasma was increased in Sev-infected WT mice (Figures 1B,C). By contrast, we detected significantly lower levels of MPO–DNA complexes in the lung and plasma of Sev-infected DPPI−/− mice on days 2–4 PI (Figures 1B,C). DNase 1 treatment also lowered the concentration of MPO–DNA complexes in BALF and plasma, confirming that the release of these complexes was partly NET dependent (Figure 1D).
In vitro, Sev enhanced NET release from TNF-primed, bone marrow-derived WT neutrophils (Figure 2). TNF-primed DPPI−/− neutrophils generated lower levels of NETs in response to Sev (Figure 2) although the overall rate of Sev-induced NET formation was lower compared to PMA or LPS stimulation (Figure 2). Regardless of the stimulus, DPPI−/− neutrophils consistently generated lower level of NETs, consistent with the in vivo results and previous studies (13, 14). Taken together these results suggest that Sev can directly induce NETs; however, in the lung milieu following Sev infection, several inflammatory cytokines likely contribute to or enhance Sev-induced NET formation.
Figure 2. Absence of DPPI attenuates NET formation in vitro. (A) Bone marrow-derived neutrophils from WT and DPPI−/− mice were stimulated with TNF-α + Sev, PMA, or LPS for 30 min and stained for DNA with Sytox green. (B,C) Quantification of NETs with different stimuli (mean ± SEM derived from three separate experiments). *P < 0.05, **P < 0.01, ***P < 0.001.
DNase 1 Attenuates the Early Sev-Induced Alveolar Inflammation
We have previously shown that Sev infection induced the expression of several cytokines/chemokines and absence of DPPI dampened this acute inflammatory response (5). To determine whether NETs modulated the acute response following Sev infection, we examined alveolar leukocyte accumulation and cytokine expression in WT mice treated with DNase 1. Administration of DNase 1 (i.n.) significantly reduced the total number of leukocytes recruited to the alveolar space (Figure 3). In addition, the levels of several BALF inflammatory cytokines, including TNF-α and IL-6 were suppressed with DNase 1 treatment (Figure 3). The extent of suppression with DNase1 treatment was equivalent to that observed with DPPI−/− mice (Figure 3). DNase 1 treatment not only suppressed the acute cytokine response but also dampened the recruitment and activation of CD4+ and CD8+ T cells, as well as plasmacytoid DCs (CD317+ CD11c+ CD11b− Siglec-H+) (Figure 4).
Figure 3. DNase 1 treatment suppresses the acute Sev-induced inflammatory responses. WT and DPPI−/− mice were infected with Sev and their BALF harvested on day 3 PI. Some WT mice received DNase 1 i.n. on days 0–2 PI. The cells were enumerated and cell-free BALF assayed for cytokines by CBA. Values represent mean ± SEM, n = 4–5 mice per genotype/treatment group. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant.
Figure 4. DNase 1 treatment suppresses immune cell recruitment and activation. WT mice were infected with Sev and treated i.n. with HBSS or DNase 1. Cells were harvested from BAL on day 3 PI and analyzed for CD4, CD8, CD69 (activation marker), and CD317+CD11c+CD11b-SiglecH+ (plasmacytoid dendritic cell markers) by multicolor FACS analysis. Values represent mean ± SEM, n = 4–5 mice/treatment group. *P < 0.05, **P < 0.01.
To further confirm that NET plays a role in the early inflammatory responses to Sev infection, we administered Cl-amidine, a pan PAD inhibitor with preferential irreversible inactivation of the calcium bound form of PAD4 (15, 16) to Sev-infected mice. PAD4 catalyzes the conversion of specific arginine residues to citrulline (17) and is essential for the formation of NETs via PAD4-mediated citrullination of histones (18). Cl-amidine suppressed neutrophil accumulation and inflammatory cytokine release in the alveolar space (Figure 5). Combined with the DNase 1 treatment results, these findings further confirmed the involvement of NETs in early host responses to Sev.
Figure 5. Cl-amidine administration attenuates acute Sev-induced inflammatory responses. WT mice were administered Cl-amidine i.p. daily 2 days prior to infection and treatment was continued (twice a day) until sacrifice as detailed in Section “Materials and Methods.” Controls received the same i.p. regimen of DMSO/PBS (5% v/v). On day 3 BALF was collected; cells were enumerated and cell-free BALF assayed for cytokines by CBA. Values represent mean ± SEM, n = 5 mice/treatment group. **P < 0.01; ***P = 0.001; note that IL-6 level in Cl-amidine treatment group approached statistical significance (P = 0.06).
NET Containing BALF Stimulates Dendritic Cells/Macrophages to Release Inflammatory Cytokines
Previous studies suggest that the early phase antiviral cytokine response correlates with chronic lung immunopathology, including the airway remodeling and AHR that accompany the asthma phenotype (19). In addition to Th2-types cytokines, Th1 cytokines, such as TNF-α, have also been shown to play an important role in the pathogenesis of asthma. TNF-α is increased in the sputum of patients with asthma (20, 21), aggrevates AHR (22) as well as recruit inflammatory cells in animals (23). Blockade of TNF-α significantly inhibits AHR and reduces airway inflammation (24). To this end, we examined whether BALF-derived NETs from Sev-infected mice modulated TNF-α (and other inflammatory cytokine) release from in vitro GM-CSF-induced BMDCs that comprise conventional DCs and macrophages (25). We observed that NET-containing BALF from WT Sev-infected mice directly stimulated BMDCs to release substantial amount of TNF-α (as well as IL-6 and MCP-1) while BALF from DPPI−/− mice and animals treated with DNase 1 was less efficient (Figure 6A). Cl-amidine treatment also significantly attenuated the release of inflammatory cytokines by BALF-stimulated BMDCs (Figure 6B). Taken together, these above findings suggest that NETs released by recruited neutrophils play an important role in shaping the early immune response that likely impacts the Sev-induced chronic lung immunopathology.
Figure 6. BALF from Sev-infected mice stimulates cytokine release from BMDCs. WT and DPPI−/− mice were infected with Sev on day 0. Some WT mice were treated i.n. with DNase 1 or Cl-amidine as detailed in Section “Materials and Methods.” BALF was harvested on day 3 PI and cells were pelleted. The cell-free BALF from each genotype/treatment was added to BMDCs at a final dilution of 44%. The supernatant was collected after 48 h and assayed for cytokine levels with CBA. (A) Cytokine levels from co-cultures of BMDCs with BALF from WT, DPPI−/−, or DNase 1-treated (Tx) mice. (B) Cytokine levels from co-cultures of BMDCs with BALF from Cl-amidine-treated mice. Values represent mean ± SEM, n = 4–6 mice/treatment group. The mean of WT cytokine levels for each experimental condition was set at 100%; values are expressed as% of mean WT level. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant.
Neutrophil extracellular traps can have anti- and pro-inflammatory effects on disease pathogenesis. On the one hand, NETs have been shown to promote the resolution of neutrophilic inflammation in monosodium urate crystal-induced arthritis (gout) (26). On the other hand, NETs are increasingly implicated in driving the pathogenesis of various diseases (11, 27–31). Their role in asthma development, however, remains largely unknown. Asthma is considered an inflammatory disease involving different mediators and cell types, with eosinophil predominance. Non-eosinophilic asthma, however, comprises 50% of asthma and is often associated with accumulation of neutrophils in the airways, possibly due to bacterial endotoxin exposure as well as viral infections (32). Neutrophils are often present in acute asthma exacerbations (33) and noted in specific circumstances, such as status asthmaticus (34) but their role in asthma pathogenesis has not been extensively explored. A more recent study suggests that NETs are generated in human atopic asthmatic airways (35); however, their pathophysiologic role in allergic asthma also remains undefined. Using a physiologic murine model of Sev-induced asthma phenotype, we previously established a critical role for neutrophils and neutrophil-associated DPPI in the disease pathogenesis (5). In the studies herein, we further extend the investigation to show that neutrophil-derived DPPI is an important mediator of NET formation and NETs mediate the early inflammatory responses in Sev infection.
In addition to Sev-induced asthma phenotype, the absence of DPPI protects against various inflammatory conditions, including preclinical models of rheumatoid arthritis (36), sepsis (37), abdominal aortic aneurysm (38), and ANCA-associated glomerulonephritis (39). DPPI deficiency also attenuates early atherosclerotic lesion in LDL-receptor-deficient mice (40). A recent report established that the absence of DPPI abrogates in vitro NET formation (13). DPPI is a ubiquitously expressed cysteine protease that is required for the expression of neutrophil serine proteases (NSPs), neutrophil elastase (NE), cathepsin G (CG) and proteinase 3 (PR3) in mature neutrophils (13, 36, 41). The role of NSPs in NET formation is well accepted (42). It is suggested that NE, but not CG or PR3, translocates to the nucleus where it contributes to chromatin decondensation by cleaving histones, an essential step in NET formation (43, 44). However, Martinod et al. recently showed that NE is dispensable for in vitro and in vivo NETs (45). Consistent with these results, we found that murine NE-deficient neutrophils release normal levels of NETs in vitro in response to various stimuli while the absence of NE and PR3 results in a NET defect similar to that observed with DPPI-deficient neutrophils (14). These discrepancies may reflect species-dependent requirements for NET formation, as previous studies used human neutrophils and NSP inhibitors.
Airway remodeling is an important histologic and structural change seen in asthma. It is a complex and incompletely understood process, involving several cell types and mediators. Neutrophils have been linked to airway remodeling presumably through their ability to release proteases, including metalloproteases and NE that induce degradation of extracellular matrix and modulate inflammatory cell trafficking (46–48). Herein, we show that DNase 1 treatment significantly reduced the recruitment and activation of leukocytes, including CD4+ and CD8+ T cells, in the acute phase PI and suppressed inflammatory cytokine release. BALF from DNase 1- and Cl-amidine-treated animals was also less efficient at stimulating bone marrow-derived macrophages and DCs from releasing inflammatory cytokines. Taken together these results suggest that NETs released during the acute phase of Sev infection induce airway inflammation, leading to the elaboration of inflammatory cytokines that further recruit and activate immune cells, thus promoting the eventual chronic asthma phenotype.
In summary, these findings suggest that controlling neutrophil activation and NET formation in non-eosinophilic asthma may attenuate acute exacerbations and potentially prevent further airway remodeling.
AA and LS designed and performed the experiments, and analyzed the data; AA, LS, and CP wrote the manuscript. All authors approved the final version of the manuscript.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
This work was supported in part by NIH grants AR067491, AI051436, and an AAF Scholar Award to CP.
3. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med (2000) 161:1501–7. doi:10.1164/ajrccm.161.5.9906076
4. Walter MJ, Morton JD, Kajiwara N, Agapov E, Holtzman MJ. Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J Clin Invest (2002) 110:165–75. doi:10.1172/JCI0214345
5. Akk AM, Simmons PM, Chan HW, Agapov E, Holtzman MJ, Grayson MH, et al. Dipeptidyl peptidase I-dependent neutrophil recruitment modulates the inflammatory response to sendai virus infection. J Immunol (2008) 180:3535–42. doi:10.4049/jimmunol.180.5.3535
9. Raptis SZ, Shapiro SD, Simmons PM, Cheng AM, Pham CT. Serine protease cathepsin G regulates adhesion-dependent neutrophil effector functions by modulating integrin clustering. Immunity (2005) 22:679–91. doi:10.1016/j.immuni.2005.03.015
10. Farley K, Stolley JM, Zhao P, Cooley J, Remold-O’Donnell E. A serpinB1 regulatory mechanism is essential for restricting neutrophil extracellular trap generation. J Immunol (2012) 189:4574–81. doi:10.4049/jimmunol.1201167
11. Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A (2010) 107:9813–8. doi:10.1073/pnas.0909927107
12. Caudrillier A, Kessenbrock K, Gilliss BM, Nguyen JX, Marques MB, Monestier M, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest (2012) 122:2661–71. doi:10.1172/JCI61303
13. Sorensen OE, Clemmensen SN, Dahl SL, Ostergaard O, Heegaard NH, Glenthoj A, et al. Papillon-Lefevre syndrome patient reveals species-dependent requirements for neutrophil defenses. J Clin Invest (2014) 124:4539–48. doi:10.1172/JCI76009
14. Yan H, Zhou HF, Akk A, Hu Y, Springer LE, Ennis TL, et al. Neutrophil proteases promote experimental abdominal aortic aneurysm via extracellular trap release and plasmacytoid dendritic cell activation. Arterioscler Thromb Vasc Biol (2016) 36(8):1660–9. doi:10.1161/ATVBAHA.116.307786
15. Luo Y, Arita K, Bhatia M, Knuckley B, Lee YH, Stallcup MR, et al. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization. Biochemistry (2006) 45:11727–36. doi:10.1021/bi061180d
16. Knuckley B, Causey CP, Jones JE, Bhatia M, Dreyton CJ, Osborne TC, et al. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3. Biochemistry (2010) 49:4852–63. doi:10.1021/bi100363t
17. Wang Y, Wysocka J, Sayegh J, Lee YH, Perlin JR, Leonelli L, et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science (2004) 306:279–83. doi:10.1126/science.1101400
19. Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, Nassi SS, et al. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis (2004) 189:1856–65. doi:10.1086/386372
21. Keatings VM, O’Connor BJ, Wright LG, Huston DP, Corrigan CJ, Barnes PJ. Late response to allergen is associated with increased concentrations of tumor necrosis factor-alpha and IL-5 in induced sputum. J Allergy Clin Immunol (1997) 99:693–8. doi:10.1016/S0091-6749(97)70032-0
24. Choi IW, Sun K, Kim YS, Ko HM, Im SY, Kim JH, et al. TNF-alpha induces the late-phase airway hyperresponsiveness and airway inflammation through cytosolic phospholipase A(2) activation. J Allergy Clin Immunol (2005) 116:537–43. doi:10.1016/j.jaci.2005.05.034
25. Helft J, Bottcher J, Chakravarty P, Zelenay S, Huotari J, Schraml BU, et al. GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c(+)MHCII(+) macrophages and dendritic cells. Immunity (2015) 42:1197–211. doi:10.1016/j.immuni.2015.05.018
26. Schauer C, Janko C, Munoz LE, Zhao Y, Kienhofer D, Frey B, et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med (2014) 20:511–7. doi:10.1038/nm.3547
27. Carmona-Rivera C, Zhao W, Yalavarthi S, Kaplan MJ. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2. Ann Rheum Dis (2015) 74:1417–24. doi:10.1136/annrheumdis-2013-204837
28. Doring Y, Manthey HD, Drechsler M, Lievens D, Megens RT, Soehnlein O, et al. Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation (2012) 125:1673–83. doi:10.1161/CIRCULATIONAHA.111.046755
29. Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med (2013) 5:178ra40. doi:10.1126/scitranslmed.3005580
30. Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science (2015) 349:316–20. doi:10.1126/science.aaa8064
34. Sur S, Crotty TB, Kephart GM, Hyma BA, Colby TV, Reed CE, et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis (1993) 148:713–9. doi:10.1164/ajrccm/148.3.713
35. Dworski R, Simon HU, Hoskins A, Yousefi S. Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. J Allergy Clin Immunol (2011) 127:1260–6. doi:10.1016/j.jaci.2010.12.1103
36. Adkison AM, Raptis SZ, Kelley DG, Pham CT. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest (2002) 109:363–71. doi:10.1172/JCI0213462
38. Pagano MB, Bartoli MA, Ennis TL, Mao D, Simmons PM, Thompson RW, et al. Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms. Proc Natl Acad Sci U S A (2007) 104:2855–60. doi:10.1073/pnas.0606091104
39. Schreiber A, Pham CT, Hu Y, Schneider W, Luft FC, Kettritz R. Neutrophil serine proteases promote IL-1beta generation and injury in necrotizing crescentic glomerulonephritis. J Am Soc Nephrol (2012) 23:470–82. doi:10.1681/ASN.2010080892
40. Herias V, Biessen EA, Beckers C, Delsing D, Liao M, Daemen MJ, et al. Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses. Arterioscler Thromb Vasc Biol (2015) 35:79–86. doi:10.1161/ATVBAHA.114.304292
41. Pham CT, Ivanovich JL, Raptis SZ, Zehnbauer B, Ley TJ. Papillon-Lefevre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans. J Immunol (2004) 173:7277–81. doi:10.4049/jimmunol.173.12.7277
42. Remijsen Q, Kuijpers TW, Wirawan E, Lippens S, Vandenabeele P, Vanden Berghe T. Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ (2011) 18:581–8. doi:10.1038/cdd.2011.1
43. Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol (2010) 191:677–91. doi:10.1083/jcb.201006052
44. Metzler KD, Goosmann C, Lubojemska A, Zychlinsky A, Papayannopoulos V. A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis. Cell Rep (2014) 8:883–96. doi:10.1016/j.celrep.2014.06.044
45. Martinod K, Witsch T, Farley K, Gallant M, Remold-O’Donnell E, Wagner DD. Neutrophil elastase-deficient mice form neutrophil extracellular traps in an experimental model of deep vein thrombosis. J Thromb Haemost (2016) 14:551–8. doi:10.1111/jth.13239
46. Legrand C, Gilles C, Zahm JM, Polette M, Buisson AC, Kaplan H, et al. Airway epithelial cell migration dynamics. MMP-9 role in cell-extracellular matrix remodeling. J Cell Biol (1999) 146:517–29. doi:10.1083/jcb.146.2.517
47. Vignola AM, Bonanno A, Mirabella A, Riccobono L, Mirabella F, Profita M, et al. Increased levels of elastase and alpha1-antitrypsin in sputum of asthmatic patients. Am J Respir Crit Care Med (1998) 157:505–11. doi:10.1164/ajrccm.157.2.9703070
48. Nakamura H, Yoshimura K, McElvaney NG, Crystal RG. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest (1992) 89:1478–84. doi:10.1172/JCI115738
Keywords: neutrophils, NETs, cytokines, dipeptidyl peptidase I, Sendai virus-induced asthma
Citation: Akk A, Springer LE and Pham CTN (2016) Neutrophil Extracellular Traps Enhance Early Inflammatory Response in Sendai Virus-Induced Asthma Phenotype. Front. Immunol. 7:325. doi: 10.3389/fimmu.2016.00325
Received: 27 April 2016; Accepted: 15 August 2016;
Published: 26 August 2016
Edited by:Marko Radic, University of Tennessee, USA
Reviewed by:Luis Enrique Munoz, Friedrich-Alexander University, Germany
Martin Herrmann, Universitätsklinikum Erlangen, Germany
Copyright: © 2016 Akk, Springer and Pham. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Christine T. N. Pham, email@example.com